Yes, Cardizem (diltiazem) is a calcium channel blocker. The FDA classifies it specifically as a “calcium ion cellular influx inhibitor,” meaning it works by blocking calcium from entering the cells of your heart and blood vessel walls. This relaxes blood vessels and slows the heart rate, which is why it’s prescribed for high blood pressure, chest pain from angina, and certain heart rhythm problems.
But not all calcium channel blockers work the same way. Cardizem belongs to a specific subtype that affects the heart differently than more commonly prescribed options like amlodipine. Understanding that distinction matters if you’re comparing medications or wondering why your doctor chose one over another.
Non-Dihydropyridine vs. Dihydropyridine
Calcium channel blockers split into two main categories: dihydropyridines and non-dihydropyridines. Cardizem falls into the non-dihydropyridine group, alongside verapamil. The dihydropyridine group includes drugs like amlodipine, nifedipine, and felodipine.
The practical difference comes down to where each type acts most strongly. Dihydropyridine calcium channel blockers work primarily on blood vessels in the body’s periphery, relaxing arteries to lower blood pressure. They have relatively little direct effect on the heart itself. Non-dihydropyridines like Cardizem act more centrally, directly slowing the heart rate and reducing the force of each heartbeat in addition to relaxing blood vessels.
This is why Cardizem is often chosen for people who need both blood pressure control and heart rate management. It pulls double duty in a way that amlodipine, for instance, does not. It also explains why Cardizem is commonly used to control rapid heart rhythms like atrial fibrillation, where slowing the heart rate is the primary goal.
What Cardizem Is Prescribed For
Cardizem has two main FDA-approved uses. The first is treating high blood pressure. Lowering blood pressure reduces the long-term risk of strokes and heart attacks, and Cardizem can be used on its own or combined with other blood pressure medications. The second approved use is improving exercise tolerance in people with chronic stable angina, the type of chest pain that comes on predictably with physical exertion.
Beyond these labeled uses, diltiazem is widely prescribed to control heart rate in atrial fibrillation and other fast heart rhythms. In hospital settings, it’s often given intravenously for rapid rate control, then transitioned to an oral form for ongoing management.
Available Formulations
Cardizem comes in several versions designed to release the medication at different speeds. The original immediate-release tablet requires dosing multiple times per day. Extended-release versions, sold under names like Cardizem CD and Cardizem LA, are taken once daily. Cardizem CD capsules deliver more than 95% absorption compared to the immediate-release tablets, so the medication gets into your system efficiently despite the slower release.
For high blood pressure, the extended-release form typically starts at 180 to 240 mg once daily, with a usual range of 240 to 360 mg. Some people need up to 480 mg daily. For angina, starting doses tend to be slightly lower, at 120 to 180 mg once daily, and are adjusted over one to two weeks based on response. Full blood pressure effects typically take about 14 days of consistent use to appear, so dosage changes are usually spaced at least that far apart.
If you’re switching between formulations, your doctor will generally match your total daily dose rather than starting over with a new titration.
Common Side Effects
Because Cardizem lowers blood pressure and slows heart rate by design, its most common side effects are extensions of those same effects. In clinical trials of the injectable form, low blood pressure with symptoms like dizziness or lightheadedness occurred in about 3.2% of patients. Flushing affected roughly 1.7%, and minor heart rhythm changes occurred in about 1% of patients.
With oral forms, the side effect profile is similar. Dizziness, headache, swelling in the lower legs, and fatigue are the complaints that come up most often. These tend to be dose-related, meaning they’re more likely at higher doses and often improve if the dose is reduced.
Who Should Not Take Cardizem
Cardizem’s ability to slow heart rate and lower blood pressure makes it unsafe in certain situations. It is contraindicated in people with sick sinus syndrome or second- or third-degree heart block unless they have an implanted pacemaker to maintain their heart rhythm. It should also not be used if your systolic blood pressure is already below 90, since the drug would push it even lower.
People who have had a heart attack complicated by fluid buildup in the lungs should not take Cardizem either. The drug’s tendency to reduce the heart’s pumping force can worsen congestion in that scenario. This is also why non-dihydropyridine calcium channel blockers are generally avoided in people with significant heart failure, where the heart is already struggling to pump effectively.
If you’re taking other medications that slow heart rate, particularly beta-blockers, combining them with Cardizem requires careful monitoring. Both drug classes reduce heart rate through different mechanisms, and the combined effect can sometimes slow the heart more than intended.